Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Up – Still a Buy?

Shares of Eurofins Scient (OTCMKTS:ERFSFGet Free Report) gapped up prior to trading on Thursday . The stock had previously closed at $76.35, but opened at $82.22. Eurofins Scient shares last traded at $82.22, with a volume of 6 shares.

Analysts Set New Price Targets

Several equities analysts recently weighed in on ERFSF shares. BNP Paribas Exane raised shares of Eurofins Scient to an “outperform” rating in a research note on Monday, January 5th. Citigroup reissued a “neutral” rating on shares of Eurofins Scient in a report on Monday, February 2nd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Eurofins Scient in a report on Wednesday, October 29th. One investment analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold”.

Read Our Latest Research Report on Eurofins Scient

Eurofins Scient Stock Performance

The company has a fifty day moving average of $79.51 and a two-hundred day moving average of $74.96. The company has a current ratio of 1.26, a quick ratio of 1.19 and a debt-to-equity ratio of 0.77.

About Eurofins Scient

(Get Free Report)

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.

Further Reading

Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.